JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Detecting mir-155-3p through a Molecular Beacon Bead-Based Assay

  • 0CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.
Molecules (basel, Switzerland) +

|

July 13, 2024

|

July 13, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study introduces a novel microfluidic assay for detecting miR-155-3p, a key biomarker for lung cancer (LC). The rapid and sensitive molecular beacon assay offers a promising alternative to traditional methods for lung cancer diagnostics.

Area Of Science

  • Biomedical Engineering
  • Molecular Biology
  • Cancer Research

Background

  • Lung cancer (LC) is a leading cause of cancer-related mortality globally.
  • MicroRNAs (miRNAs) show potential as biomarkers for disease detection and progression, including LC.
  • Existing miRNA detection methods like PCR are often slow and costly.

Purpose Of The Study

  • To develop and validate a rapid, sensitive, and cost-effective microfluidic assay for detecting miR-155-3p, a lung cancer biomarker.
  • To utilize a molecular beacon (MB) bead-based assay integrated into a microfluidic device for enhanced miRNA detection.
  • To assess the assay's performance in complex biological samples.

Main Methods

  • A microfluidic device was employed to immobilize molecular beacon (MB) probes for miRNA detection.
  • The assay leverages fluorescence enhancement of MBs upon hybridization with the target miR-155-3p.
  • Performance was evaluated using miR-155-3p in saline, A549 cell total RNA, and spiked peripheral blood mononuclear cells (PBMCs).

Main Results

  • The microfluidic MB assay successfully detected miR-155-3p with a limit of detection (LOD) of 42 nM in saline.
  • Satisfactory recovery rates were achieved when testing the assay with A549 cell total RNA and spiked PBMCs.
  • The assay demonstrated rapid and straightforward target detection capabilities.

Conclusions

  • The developed microfluidic molecular beacon assay provides a promising platform for sensitive and rapid detection of lung cancer-associated miRNAs.
  • This approach offers a potential alternative to conventional, time-consuming miRNA quantification methods.
  • Further validation in clinical samples could establish this assay for early lung cancer diagnosis.

Keywords: